Drug Shortage Report for TEVA-TELMISARTAN HCTZ

Last updated on 2021-10-14 History
Report ID 92195
Drug Identification Number 02330288
Brand name TEVA-TELMISARTAN HCTZ
Common or Proper name TELMISARTAN
Company Name TEVA CANADA LIMITED
Market Status MARKETED
Active Ingredient(s) HYDROCHLOROTHIAZIDE TELMISARTAN
Strength(s) 12.5MG 80MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 30
ATC code C09DA
ATC description ANGIOTENSIN II ANTAGONISTS, COMBINATIONS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2019-08-22
Estimated end date Unknown
Actual end date
Shortage status Actual shortage
Updated date 2021-10-14
Company comments Item is on suspended supply
Health Canada comments
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v24 2021-10-14 French Compare
v23 2021-10-14 French Compare
v22 2021-10-14 English Compare
v21 2021-02-25 French Compare
v20 2021-02-25 English Compare
v19 2020-07-16 French Compare
v18 2020-07-16 English Compare
v17 2020-05-08 French Compare
v16 2020-05-08 English Compare
v15 2020-05-08 French Compare
v14 2020-05-08 English Compare
v13 2020-04-09 French Compare
v12 2020-04-09 English Compare
v11 2019-11-28 French Compare
v10 2019-11-28 English Compare
v9 2019-11-21 French Compare
v8 2019-11-21 English Compare
v7 2019-10-31 French Compare
v6 2019-10-31 English Compare
v5 2019-10-03 French Compare

Showing 1 to 20 of 24